Cargando…

Inhibition of Extracellular Cathepsin D Reduces Hepatic Lipid Accumulation and Leads to Mild Changes in Inflammationin NASH Mice

BACKGROUND & AIMS: The lysosomal enzyme, cathepsin D (CTSD) has been implicated in the pathogenesis of non-alcoholic steatohepatitis (NASH), a disease characterised by hepatic steatosis and inflammation. We have previously demonstrated that specific inhibition of the extracellular CTSD leads to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yadati, Tulasi, Houben, Tom, Bitorina, Albert, Oligschlaeger, Yvonne, Gijbels, Marion J., Mohren, Ronny, Lütjohann, Dieter, Khurana, Princy, Goyal, Sandeep, Kulkarni, Aditya, Theys, Jan, Cillero-Pastor, Berta, Shiri-Sverdlov, Ronit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323051/ https://www.ncbi.nlm.nih.gov/pubmed/34335574 http://dx.doi.org/10.3389/fimmu.2021.675535

Ejemplares similares

The Ins and Outs of Cathepsins: Physiological Function and Role in Disease Management
por: Yadati, Tulasi, et al.
Publicado: (2020)

Inhibiting Extracellular Cathepsin D Reduces Hepatic Steatosis in Sprague–Dawley Rats †
por: Khurana, Princy, et al.
Publicado: (2019)

Inflammatory Bowel Disease: A Stressed “Gut/Feeling”
por: Oligschlaeger, Yvonne, et al.
Publicado: (2019)

OxLDL as an Inducer of a Metabolic Shift in Cancer Cells
por: Bitorina, Albert V., et al.
Publicado: (2021)

Cathepsin D regulates lipid metabolism in murine steatohepatitis
por: Houben, Tom, et al.
Publicado: (2017)

Plasma Cathepsin D Activity Rather Than Levels Correlates With Metabolic Parameters of Type 2 Diabetes in Male Individuals
por: Ding, Lingling, et al.
Publicado: (2020)

Sex‐opposed inflammatory effects of 27‐hydroxycholesterol are mediated via differences in estrogen signaling
por: Houben, Tom, et al.
Publicado: (2020)

Plasma cathepsin D activity is negatively associated with hepatic insulin sensitivity in overweight and obese humans
por: Ding, Lingling, et al.
Publicado: (2019)

Macrophage Stimulating Protein Enhances Hepatic Inflammation in a NASH Model
por: Li, Jieyi, et al.
Publicado: (2016)

Blood-derived macrophages prone to accumulate lysosomal lipids trigger oxLDL-dependent murine hepatic inflammation
por: Houben, Tom, et al.
Publicado: (2017)

All Roads Lead to Cathepsins: The Role of Cathepsins in Non-Alcoholic Steatohepatitis-Induced Hepatocellular Carcinoma
por: van Mourik, Hester, et al.
Publicado: (2022)

Pro-Inflammatory Implications of 2-Hydroxypropyl-β-cyclodextrin Treatment
por: Houben, Tom, et al.
Publicado: (2021)

COVID‐19 infection, progression, and vaccination: Focus on obesity and related metabolic disturbances
por: Westheim, Annemarie J. F., et al.
Publicado: (2021)

Myeloid DLL4 Does Not Contribute to the Pathogenesis of Non-Alcoholic Steatohepatitis in Ldlr(-/-) Mice
por: Jeurissen, Mike L. J., et al.
Publicado: (2016)

NASH and Systemic Complications: From Basic to Clinical Research
por: Baumgartner, Sabine, et al.
Publicado: (2021)

NAFLD Preclinical Models: More than a Handful, Less of a Concern?
por: Oligschlaeger, Yvonne, et al.
Publicado: (2020)

Anti-Inflammatory Effects of Dietary Plant Stanol Supplementation Are Largely Dependent on the Intake of Cholesterol in a Mouse Model of Metabolic Inflammation
por: Magro dos Reis, Inês, et al.
Publicado: (2021)

Cysteamine Decreases Low‐Density Lipoprotein Oxidation, Causes Regression of Atherosclerosis, and Improves Liver and Muscle Function in Low‐Density Lipoprotein Receptor–Deficient Mice
por: Ahmad, Feroz, et al.
Publicado: (2021)

Plasma cathepsin D correlates with histological classifications of fatty liver disease in adults and responds to intervention
por: Walenbergh, Sofie M. A., et al.
Publicado: (2016)

Pneumococcal Immunization Reduces Neurological and Hepatic Symptoms in a Mouse Model for Niemann-Pick Type C1 Disease
por: Houben, Tom, et al.
Publicado: (2019)

Insight into the Antioxidant Effect of Fermented and Non-Fermented Spirulina Water and Ethanol Extracts at the Proteome Level Using a Yeast Cell Model
por: Masten Rutar, Jasmina, et al.
Publicado: (2021)

Lipid surface modifications increase mesoporous silica nanoparticle labeling properties in mesenchymal stem cells
por: Rosenbrand, Roger, et al.
Publicado: (2018)

MSP is a negative regulator of inflammation and lipogenesis in ex vivo models of non-alcoholic steatohepatitis
por: Chanda, Dipanjan, et al.
Publicado: (2016)

Comment on Tauriainen et al.: Serum, liver and bile sitosterol and sitostanol in obese patients with and without NAFLD
por: Plat, Jogchum, et al.
Publicado: (2018)

Hematopoietic Npc1 mutation shifts gut microbiota composition in Ldlr(−/−) mice on a high-fat, high-cholesterol diet
por: Houben, Tom, et al.
Publicado: (2019)

Internalization of Modified Lipids by CD36 and SR-A Leads to Hepatic Inflammation and Lysosomal Cholesterol Storage in Kupffer Cells
por: Bieghs, Veerle, et al.
Publicado: (2012)

The Influence of a Conjugated Pneumococcal Vaccination on Plasma Antibody Levels against Oxidized Low-Density Lipoprotein in Metabolic Disease Patients: A Single-Arm Pilot Clinical Trial
por: Shiri-Sverdlov, Ronit, et al.
Publicado: (2021)

LDL Receptor Knock-Out Mice Are a Physiological Model Particularly Vulnerable to Study the Onset of Inflammation in Non-Alcoholic Fatty Liver Disease
por: Bieghs, Veerle, et al.
Publicado: (2012)

Oxidized LDL in Inflammation: From Bench to Bedside
por: Tekin, Ishak Ozel, et al.
Publicado: (2013)

Mediators of Gut Mucosal Immunity and Inflammation
por: Tekin, Ishak Ozel, et al.
Publicado: (2015)

Fatty Acids as a Tool to Boost Cancer Immunotherapy Efficacy
por: Westheim, Annemarie J. F., et al.
Publicado: (2022)

The Modulatory Effects of Fatty Acids on Cancer Progression
por: Westheim, Annemarie J. F., et al.
Publicado: (2023)

Proteomics analysis of human intestinal organoids during hypoxia and reoxygenation as a model to study ischemia-reperfusion injury
por: Kip, Anna M., et al.
Publicado: (2021)

Weekly Treatment of 2-Hydroxypropyl-β-cyclodextrin Improves Intracellular Cholesterol Levels in LDL Receptor Knockout Mice
por: Walenbergh, Sofie M. A., et al.
Publicado: (2015)

AntagomiR-103 and -107 Treatment Affects Cardiac Function and Metabolism
por: Rech, Monika, et al.
Publicado: (2018)

Cell Autophagy in NASH and NASH-Related Hepatocellular Carcinoma
por: Udoh, Utibe-Abasi S., et al.
Publicado: (2022)

Depletion of CD40 on CD11c(+) cells worsens the metabolic syndrome and ameliorates hepatic inflammation during NASH
por: Aarts, Suzanne, et al.
Publicado: (2019)

Nash vek /
por: Nappelʹbaum, Moisei Solomonovich, 1869-1958
Publicado: (1984)

Nash manifolds
por: Shiota, Masahiro
Publicado: (1987)

Modeling NASH and NASH-Induced Hepatocellular Carcinoma: Faster and Better
por: Hirsova, Petra
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vr0vcphvq4cblgnfb4kqf7d0pb